Company
CureVac
TübingenBiotechnologyHealth CareTherapeuticsDescription
CureVac N.V., a global biopharmaceutical company, has announced the appointment of Thaminda Ramanayake to the role of Chief Business Officer, effective June 1, 2024. Mr. Ramanayake brings over fifteen years of experience in biopharma company development and deal-making, with a strong track record of successful clinical collaborations, M&A, asset in-licensing, and strategic financing initiatives across multiple therapeutic areas.
Quick answer
CureVac N.V. Appoints Thaminda Ramanayake as Chief Business Officer (April 29, 2024). CureVac is based in Tübingen, Baden-Württemberg, Germany.
- What did CureVac announce on April 29, 2024?
- CureVac N.V., a global biopharmaceutical company, has announced the appointment of Thaminda Ramanayake to the role of Chief Business Officer, effective June 1, 2024. Mr. Ramanayake brings over fifteen years of experience in biopharma company development and deal-making, with a strong track record of successful clinical collaborations, M&A, asset in-licensing, and strategic financing initiatives across multiple...
- What does CureVac do?
- CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine.
- Where is CureVac based?
- CureVac is based in Tübingen, Baden-Württemberg, Germany.
- Which similar companies made leadership changes around the same time?
- Evox Therapeutics Ltd (April 29, 2024), Stoke Therapeutics, Inc. (April 29, 2024), Insitro (April 30, 2024) and Akero Therapeutics (April 30, 2024) also announced leadership changes within 45 days of CureVac.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Evox Therapeutics Appoints Dr. Per Lundin as Chief Executive Officer (April 29, 2024)
- Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer (April 29, 2024)
- insitro Appoints Emily Fox, Ph.D. as Senior Vice President of AI/Machine Learning (April 30, 2024)
- Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer (April 30, 2024)
- BioVaxys Technology Corp Appoints Christopher Cherry as Chief Financial Officer (April 30, 2024)
- Immunome Names Kinney Horn as Chief Business Officer (May 2, 2024)
Who to call at CureVac, and when
A new leader at CureVac brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CureVac raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CureVac, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CureVac. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CureVac changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CureVac changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.